noom.semaglutide Weight-loss company Noom pivots to smaller doses of compounded Wegovy Noom dosing card for 5mg/2ml

The Broader Impact of GLP-1 Agonists While the primary function of GLP-1 agonists is to manage blood sugar levels and promote weight loss, their broader impact on health and behavior cannot be overstated

Here are some tried-and-true habits to make every snack more satisfying: Build snacks around protein and fibre

How PlexusDx Supports a More Personalized Approach PlexusDx compounded GLP-1 medications address the affordability barrier while offering optional genetic insights

The majority of clinical trials investigating disease-modifying therapies have sought to halt or reverse the deposition of specific proteins in the brain and, while the first disease-modifying drug targeting protein deposition has been approved for AD (Cummings, 2023), two different phase II clinical trials of antibodies targeting -synuclein in PD patients have not shown any effect on symptom relief (Kharel and Ojha, 2023)

That followed OASIS-4: a Phase 3 trial showing 13.6% mean weight loss over 64 weeks